Skip to content

License digital pathology slides for AI

Pathology archives hold glass slides and scanned whole-slide images. Linked to diagnoses and outcomes, they train cancer models. Health data (patient records, medical imaging and veterinary records) stays with its owner: Rightmark describes it to buyers by counts only, the owner de-identifies it on site before any licensed delivery, and Rightmark never stores or hosts it.

Price Index, Q4 2026
AI-generated footage

Digital pathology slides, scanned as whole-slide images and linked to diagnoses, can be licensed to oncology AI developers, usually for a revenue share. The one public per-slide benchmark, listed with its source below, is implied by an acquisition that also bought products and models. Slides linked to molecular and outcome data earn the most; unscanned glass must be digitized first.

Updated

Timeline
Months
de-identification and contracts come first (inferred)
You keep
Ownership
Routes: Revenue-share marketplace (non-exclusive revenue share); Direct license to a medical AI developer (non-exclusive).

Why AI buyers want it

Oncology AI needs slides from many labs, stains and scanners to generalize beyond the site that trained it. Slides linked to molecular and outcome data are the scarcest and most valuable, because they let a model learn what a pattern on the glass led to.

Think of it this way

A slide archive works like a seed bank: most of it sits unused, but it holds the variety that future models need.

What sets the price

  • Scanned whole-slide images, or slides you can scan.
  • Linked diagnoses, molecular data and outcomes.
  • A range of stains and scanners.
  • Rare cancers and diverse populations.

Our estimate of what a revenue share could total for a research archive with linked data, kept under the acquisition-implied benchmark on the Price Index, which also bought products and models, so read it as rough.

What blocks a deal, and the fix

Slides not yet digitized
Slides must be scanned before they can be licensed. Scanning is a cost to you and licensing income is not certain, so we judge with you from your volumes and stains whether it is worth it.
Label text on the glass and metadata in image files
Both are redacted during de-identification and checked on samples.
Genomic data linked to slides
US rules on bulk sensitive data restrict some transfers of genomic data even at small volumes, so destinations are checked against them before any agreement.

What owners overlook

  • Glass in storage becomes an asset only once it is scanned.
  • Annotations made by your pathologists can be licensed separately from the slides.
  • Stain and scanner variety is a selling point, not a defect: it is what lets a model generalize.

Market evidence

How a deal works

  1. Appraise

    Answer a few questions about your records. See what affects the price and whether an indicative range is available. No files, no access.

    About a minute

  2. Verify title

    We confirm you control the data, read your vendor and data-use contracts, and plan de-identification to the HIPAA standard before anything leaves your systems.

    Before any offer

  3. Route

    We match the data to the license routes that fit it and show you the terms of each before you decide. Nothing is offered without your approval.
  4. Sign and get paid

    You approve the agreement and its scope before anything moves. We never hold your passwords. Transfers use scoped, revocable connections your admins approve, or exports.

    Allow months: de-identification and contracts come first

Questions

What is a whole-slide image worth?

No buyer publishes a per-slide price, and deals are usually revenue shares. The one public benchmark is implied by an acquisition that also bought products and models, so read it as rough; the answer above lists it with its source. The estimate on this page (50,000 slides at $4.80 to $11 per slide) stays below it.

Source: BusinessWire, (opens in a new tab)

We have not digitized our slides. Is it worth it?

Sometimes. Licensing can offset scanning costs, but nothing promises it will repay them; we look at your volumes and stains before you spend anything.

Which slides are most valuable?

Slides linked to diagnoses, molecular results and outcomes, from many stains and scanners, and from rare cancers and diverse populations.

Is pathology data covered by HIPAA?

Yes, when it comes from a covered entity. Slides and reports must be de-identified, including label text on the glass and metadata in the image files, before licensing.

Source: HHS, (opens in a new tab)

How long does a pathology deal take?

Allow months, and longer if slides still need scanning. Scanning, de-identification of labels and file metadata, and the contract review come first. No buyer timeline for health data is published, so this is our inferred guide, confirmed at scoping.

Who owns a slide archive, the lab or the hospital?

It depends on your service agreements. Reference labs often process slides for many hospitals, so the contracts decide who may license them. You warrant that you hold the rights you license, so we read those agreements with you first.

Get an indicative range for your Pathology slides.

About a minute to appraise. No files, no access.

Find out what your data could be worth.

Start with an indicative appraisal. No files or system access needed.

Appraise your data

What brings you to Rightmark?